Browsing Tag
Paul Armentano
12 posts
Anti-Pot Org Claims DEA Administrator Was Not Included in Rescheduling Decision
Kevin Sabet, co-founder of Smart Approaches to Marijuana, claims DEA head Anne Milgram did not sign off on rescheduling cannabis to Schedule III.
Cannabis Community, Investors React to DEA Decision To Reschedule
Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many activists say the move does not go far enough.
DEA Moves To Reclassify Cannabis Under Schedule III in Historic Move, Report Indicates
The DEA under the Biden administration finally proposed the process of moving cannabis to Schedule III.
Study: Canadian MJ Legalization Has No Association with Increasing Psychosis Rates
While research has shown associations between heavy cannabis use and those individuals who already possess certain risk factors, a new study affirms that cannabis legalization is not linked to increasing rates of cannabis-related psychosis in Canada.
30,000 Papers on Cannabis Published By Scientists in Last Decade
More than 70% of all peer-reviewed scientific research on cannabis has been published in the past ten years.
Study: Young MJ Consumers With Psychosis Risk Saw Symptom Improvement
Among a number of recent studies claiming that cannabis use is associated with developing psychosis, a new study shows evidence to the contrary.
Study: Smoking Pot Not Linked With COPD
The findings on COPD come via researchers at UCLA.
Cannabis Researchers Published 4,300 Scientific Papers in 2022
Cannabis researchers pulled out all the stops this year and published over 4,000 studies in 2022.
Cannabis Legalization Hearing Held by Congressional Committee
Multiple U.S. Representatives questioned seven cannabis advocates to discuss legalization at the federal level in a recent hearing.
People With First-Hand Experience More Likely to Perceive Pot Positively
The latest Gallup polling data indicates that 70% of Americans who have tried cannabis thinks its effects on users are positive.